1. Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis. Issue 11 (2nd October 2014) Authors: Baert, F.; Vande Casteele, N.; Tops, S.; Noman, M.; Van Assche, G.; Rutgeerts, P.; Gils, A.; Vermeire, S.; Ferrante, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 11/12(2014) Page Start: 1324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis. Issue 11 (2nd October 2014) Authors: Baert, F.; Vande Casteele, N.; Tops, S.; Noman, M.; Van Assche, G.; Rutgeerts, P.; Gils, A.; Vermeire, S.; Ferrante, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 11/12(2014) Page Start: 1324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗